Categories
Videos

State of the Pandemic Davos 2023 – World Economic Forum

At the 2023 WEF meeting in Davos, Moderna CEO Stephane Bancel indicates that in 2019, he had advance knowledge of a pandemic:

Sasha Vakulina, panel host: “How is the development, adoption and scaling of vaccine going on when it comes to different variants and subvariants? Because this is one of the big concerns, as we’re all here now and we’re discussing and we understand the context and this is a great deal.”

Bancel: “Sure. Good morning and thank you for having me on the panel. So the great news versus 2020 where we are today is we have manufacturing capacity.

“When the pandemic happened, Moderna made 100,000 doses in 2019 for the whole year. And I remember walking after hours into the office of Moderna manufacturing and I say, ‘How (can) we make a billion doses next year?’ And they look at me a bit funny, say, ‘What?’ I say, ‘Yeah, we need to make a billion doses next year, there’s going to be a pandemic.

“And so where we are now is we have plants in the US and in Switzerland. We’ve shown this summer that we’re able to adapt to variants very quickly.”

Categories
Opinion

Breaking the silence: do mRNA vaccine harms outweigh benefits? – Dr. Julie Sladden, The Spectator

Double-jabbed’ Malhotra originally supported the program, until a series of events sent him digging into the evidence. What he discovered alarmed him and resulted in the publication of two evidence-based, peer-reviewed papers along with a call for the immediate suspension of the Covid mRNA roll-out…

Over following months, emerging data led Malhotra to question whether the vaccine was linked to his father’s death. The first was an abstract published in Circulation (November 8, 2021) by US cardiothoracic surgeon, Dr Steven Gundry, who followed several hundred of his patients after the mRNA (Moderna/Pfizer) jabs. Gundry found that inflammatory markers correlated with heart disease risk went through the roof. On average, that change increased the risk of those people having a heart attack or stroke within the next five years, from 11 per cent up to 25 per cent. This increase in risk is massive.

https://archive.today/2023.01.25-065118/https://www.spectator.com.au/2023/01/breaking-the-silence-do-mrna-vaccine-harms-outweigh-benefits/

Categories
Videos

Neil Oliver Interviews Dr. John Campbell – Dr. John Campbell

Dr. John Campbell is an internet sensation, giving facts & data to help us navigate healthcare in the present day. The interview covers John’s development, work, rise to fame & what he would do to help get healthcare back in shape.

Categories
Publications

CDC and FDA Identify Preliminary COVID-19 Vaccine Safety Signal for Persons Aged 65 Years and Older – FDA

Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-44 following vaccination.

https://web.archive.org/web/20230113214706/https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/cdc-and-fda-identify-preliminary-covid-19-vaccine-safety-signal-persons-aged-65-years-and-older

Categories
News

CDC identifies possible ‘safety concern’ for certain people receiving COVID vaccines – Fox News

The Centers for Disease Control and Prevention (CDC) says that a preliminary COVID-19 vaccine “safety signal” has been identified and is investigating whether the Bivalent Pfizer-BioNTech vaccine creates an increased risk of ischemic stroke in people 65 and older.

In the Friday statement, the CDC said that the preliminary signal hasn’t been identified with the Bivalent Moderna COVID-19 vaccine.

https://archive.today/2023.01.13-203714/https://www.foxnews.com/health/cdc-identifies-possible-safety-concern-certain-people-receiving-covid-vaccines

Categories
Publications

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older – Science Direct

Findings
Four outcomes met the threshold for a statistical signal following BNT162b2 vaccination including pulmonary embolism (PE; RR = 1.54), acute myocardial infarction (AMI; RR = 1.42), disseminated intravascular coagulation (DIC; RR = 1.91), and immune thrombocytopenia (ITP; RR = 1.44). After further evaluation, only the RR for PE still met the statistical threshold for a signal; however, the RRs for AMI, DIC, and ITP no longer did. No statistical signals were identified following vaccination with either the mRNA-1273 or Ad26 COV2.S vaccines.

Interpretation
This early warning system is the first to identify temporal associations for PE, AMI, DIC, and ITP following BNT162b2 vaccination in the elderly. Because an early warning system does not prove that the vaccines cause these outcomes, more robust epidemiologic studies with adjustment for confounding, including age and nursing home residency, are underway to further evaluate these signals. FDA strongly believes the potential benefits of COVID-19 vaccination outweigh the potential risks of COVID-19 infection.

http://archive.today/2023.01.10-210629/https://www.sciencedirect.com/science/article/pii/S0264410X22014931

Categories
News

FDA and CDC advisors accuse Moderna of withholding trial data that suggested its Covid bivalent booster was LESS effective than older shot — to secure $5bn Government order – Daily Mail

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant’s bivalent Covid booster.

Vaccine advisors who signed off on the updated shot late last year claim they were not shown trial data that indicated the booster was actually less effective at preventing Covid than the older vaccine it was meant to replace.

While the early trial results had substantial limitations, ‘disappointed’ and ‘angry advisors say its omission from panel discussions shows a remarkable lack of transparency.

https://archive.today/2023.01.30-023930/https://www.dailymail.co.uk/health/article-11624959/FDA-CDC-vaccine-advisers-angry-early-data-Covid-19-booster-shot-withheld-year.html

Categories
News

Myocarditis after Covid vaccination: Research on possible long-term risks underway – NBC News

The vast majority of cases occur in young men, ages 16 to 24, according to the CDC. The agency did not have data available on the total number of cases in young adults 24 and younger, but it estimates there have been 52.4 cases and 56.3 cases per million doses of Pfizer’s and Moderna’s vaccines, respectively.

Symptoms of myocarditis include:

  • Chest pain
  • Shortness of breath
  • Feelings of having a fast-beating, fluttering or pounding heart

A study by Canadian researchers published Monday in the Journal of the American College of Cardiology found that men younger than 40 who got the Moderna vaccine had the highest risk of heart issues, usually within 21 days after the second dose. The study was observational, meaning it doesn’t prove cause and effect but it is one of only a few studies to compare the risk of myocarditis between the Pfizer and the Moderna vaccines.

http://archive.today/2022.11.13-223941/https://www.nbcnews.com/health/health-news/myocarditis-covid-vaccine-research-long-term-effects-rcna55666

Categories
Publications

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States – Annals of Internal Medicine

 From 14 December 2020 through 31 May 2022 (persons 18–39 years) and 20 August 2022 (persons 5–17 years), 320 potential cases of myocarditis/pericarditis were identified 1 to 98 days after 6 992 340 vaccine doses as part of primary series COVID-19 vaccination, with 224 (70%) verified. Of these, 137 (61%) occurred 0 to 7 days after vaccination; 18 were after the first dose (of 3 562 311 doses administered) and 119 were after the second dose (of 3 430 029 doses administered).

In all age groups, incidence per million doses 0 to 7 days after vaccination was numerically higher in male than in female persons and after dose 2, although confidence intervals were wide and overlapped across sex for some age groups. Incidence was highest for male adolescents ages 12 to 15 years and 16 to 17 years following dose 2.

From 24 September 2021 through 20 August 2022, 101 potential cases of myocarditis/pericarditis were identified 1 to 98 days after 1 848 723 first booster doses, with 77 (76%) verified with a median onset of 4.5 days after vaccination; 39 cases (51%) were verified in the first week versus 38 during the subsequent 13 weeks.

In all age groups, incidence 0 to 7 days after first booster was higher for male compared to female persons, with adolescent males having the highest incidence in 16- to 17-year-olds and in 12- to 15-year-olds. In adults for whom both vaccine products were available, post-booster incidence was higher in male than in female adults and higher in males aged 18 to 29 compared to males aged 30 to 39.

http://archive.today/2022.10.06-094825/https://www.acpjournals.org/doi/10.7326/M22-2274

Categories
News

Up to one in 7,000 American teens suffered heart inflammation after their Covid vaccine, study suggests – DailyMail

Thousands of American teenagers may have suffered heart inflammation after getting a Covid jab, a study suggests.

Researchers found up to one in 7,000 boys aged 12 to 15 years old developed myocarditis after receiving the Pfizer vaccine.

The condition — which is mild for most but can cause a recurrent heart palpitation in rare cases — was most common after the second dose.

http://archive.today/2022.10.03-220645/https://www.dailymail.co.uk/health/article-11275889/Up-one-7-000-American-teens-suffered-heart-inflammation-Covid-vaccine.html

Categories
Publications

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults – Science Direct

Results
Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated (95 % CI 2.1 to 22.9); risk ratio 1.43 (95 % CI 1.07 to 1.92). The Pfizer trial exhibited a 36 % higher risk of serious adverse events in the vaccine group; risk difference 18.0 per 10,000 vaccinated (95 % CI 1.2 to 34.9); risk ratio 1.36 (95 % CI 1.02 to 1.83). The Moderna trial exhibited a 6 % higher risk of serious adverse events in the vaccine group: risk difference 7.1 per 10,000 (95 % CI –23.2 to 37.4); risk ratio 1.06 (95 % CI 0.84 to 1.33). Combined, there was a 16 % higher risk of serious adverse events in mRNA vaccine recipients: risk difference 13.2 (95 % CI −3.2 to 29.6); risk ratio 1.16 (95 % CI 0.97 to 1.39).

Discussion
The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes. These analyses will require public release of participant level datasets.

http://archive.today/2023.01.12-064142/https://www.sciencedirect.com/science/article/pii/S0264410X22010283

Categories
Alternative Media Videos

The biggest story of our time: What the pharmaceutical companies knew about the shots – Naomi Wolf, The Delingpod

Naomi Wolf graduated from Yale in 1984 and was a Rhodes scholar at New College, Oxford University. She is the author of the bestselling feminist books, “The Beauty Myth”, “Fire with Fire”, “Promiscuities” and “Misconceptions”. The New York Times called “The Beauty Myth” one of the 70 most significant books of the century. More recently, Naomi has written books critiquing the establishment’s advances in censorship, Covid-19 vaccinations and many more issues which she addresses with James.

Note: Title editorialised.

Categories
News

US restricts use of Johnson & Johnson Covid vaccine over rare blood clot risk

FDA officials said in a statement that they decided to restrict Johnson & Johnson’s vaccine after taking another look at data on the risk of life-threatening blood clots within two weeks of vaccination.

http://archive.today/2022.05.06-145106/https://www.theguardian.com/world/2022/may/05/us-johnson-johnson-covid-vaccine-blood-clot

Categories
Publications

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents – JAMA

The risk of myocarditis in this large cohort study was highest in young males after the second SARS-CoV-2 vaccine dose, and this risk should be balanced against the benefits of protecting against severe COVID-19 disease.

https://jamanetwork.com/journals/jamacardiology/fullarticle/2791253

Archive link: https://web.archive.org/web/20230000000000*/https://jamanetwork.com/journals/jamacardiology/fullarticle/2791253

Categories
News

Get ready for Covid vaccines every SIX months: Health chief hints millions of Brits in ‘relevant groups’ may need boosters twice-a-year for the foreseeable future – Daily Mail

Millions of Britons could need Covid boosters every six months for the foreseeable future, a health boss hinted today.

Dr Jenny Harries, chief executive of the UK Health Security Agency (UKHSA), suggested the most vulnerable ‘relevant groups’ in society will still need regular top-up jabs.

https://www.dailymail.co.uk/news/article-10660967/Health-chief-hints-relevant-groups-continue-Covid-boosters-six-months.html

Categories
News

More evidence Covid was tinkered with in a lab? Now scientists find virus contains tiny chunk of DNA that matches sequence patented by Moderna THREE YEARS before pandemic began – Daily Mail

Genetic match discovered in Covid’s unique furin cleavage site on spike protein

Matched genetic sequence patented by Moderna for cancer research purposes

Researchers say one in 3trillion chance Covid developed the code naturally 

http://archive.today/2022.02.24-054810/https://www.dailymail.co.uk/news/article-10542309/Fresh-lab-leak-fears-study-finds-genetic-code-Covids-spike-protein-linked-Moderna-patent.html

Categories
News

Covid-19 Vaccines Were Deadly in Rare Cases. Governments Are Now Weighing Compensation – Wall Street Journal

[Ms. Spit] is part of a very small, little-discussed community of pandemic victims: those who have suffered—or had family or loved ones suffer—from rare but serious vaccine side effects recognized by doctors, regulators and researchers. They say they feel lost in wider Covid-19 statistics, which have shown vaccines to be extremely safe and effective for most of the population.

Faced with the gravest health crisis in memory, governments deployed newly developed vaccines in record time. Many countries indemnified pharmaceutical companies that made the shots, with some governments promising to consider compensation for suspected Covid-19 vaccine-related injuries.

Now governments, including the U.S. and U.K., are trying to live up to that pledge. They are in the very early stages of applying existing vaccine-injury programs to hundreds of claims of injury alleged from Covid-19 shots.

…The U.K.’s National Health Service has received more than 720 claims requesting Covid-19 vaccine-related compensation. The country’s vaccine-injury compensation program entails a one-size-fits-all cash payment of £120,000, equivalent to around $163,000. The volume of Covid-related claims has grown by about 20 a week, toward a projected 1,500 to 1,800 new claims this year, according to U.K. government projections.

http://archive.today/2022.02.22-001537/https://www.wsj.com/articles/covid-19-vaccines-were-deadly-in-rare-cases-governments-are-now-weighing-compensation-11645266603

Categories
News

EU investigates reports of menstrual disorders after mRNA COVID shots – Reuters

The European Medicines Agency’s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation from women who had received COVID vaccines from Pfizer (PFE.N)/BioNTech (22UAy.DE)and Moderna (MRNA.O).

The assessment was in view of reports of menstrual disorders after receiving either of the two vaccines, both based on messenger RNA technology, and it was not yet clear whether there was a causal link, the agency said.

http://archive.today/2022.02.11-153938/https://www.reuters.com/business/healthcare-pharmaceuticals/eu-investigates-reports-menstrual-disorders-after-mrna-covid-shots-2022-02-11/

Categories
News

AstraZeneca sees $4B in COVID vaccine sales as revenue soars – AP News

AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time.

The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford.

Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research.

The Anglo-Swedish drugmaker said in November it would begin to take a “modest” profit from the COVID-19 shot, which it had been providing “at cost” — around $2 to $3 —following an agreement with Oxford. Other COVID-19 vaccine producers, such as Pfizer and Moderna, have been booking hefty profits on their shots all along.

In the three months to September, the company said revenue jumped by about 50%, to a record $9.9 billion. The increase was due to sales of more than $1 billion in COVID-19 vaccines and the inclusion for the first time of some $1.3 billion worth of revenue from its rare disease business unit following the recent acquisition of Alexion.

http://archive.today/2022.02.10-112738/https://apnews.com/article/coronavirus-pandemic-business-health-europe-oxford-d5b4503c4a21afe1a68d6a7a1bc8a460

Categories
News

UK is ‘set to bin 3.5million Pfizer vaccine doses’ despite their shelf life already being extended as rollout slows – Daily Mail

Up to 3.5million Covid vaccine doses are set to be binned after reaching their expiry date, it was revealed today.

A leaked memo last month revealed that tens of millions of jabs sent to hospitals, GP surgeries and pharmacies in the run up to Christmas to fight Omicron had largely went unused.

Now NHS sources say more than half of the doses sent to some clinics are still ‘sitting in fridges’ amid falling demand for the booster shots. 

One well-placed official estimated up to 3.5m doses are likely to be binned, based on stock counts in several English regions, the Health Service Journal reports.

http://archive.today/2022.02.05-174202/https://www.dailymail.co.uk/news/article-10476167/UK-set-bin-3-5million-Pfizer-vaccine-doses-despite-shelf-life-extended.html